CMR Surgical is developing next-generation robotic systems for minimal access surgery.

 

Background

  • CMR Surgical is a Cambridge UK-based company developing a next-generation surgical robot Versius®
  • Announced a Series C fundraise of $240 million in September 2019, Europe’s largest private financing round in the medical technology sector
  • Financing to support the global commercial scale up of the business

$240 million

Series C fundraise in 2019

 

Our strategy

  • Develop and execute an international profile raising strategy in order to create maximum impact of the news
  • Arrange under embargo interviews with strategically targeted business and trade journalists 

 

Outcome

  • Significant media coverage across international business media and trade publications including the Financial Times, The Telegraph, MedTech Insight, Fierce MedTech, and BioWorld MedTech